Transmyringeal ventilation tube insertion for unilateral Menière's disease: a protocol for a prospective, sham-controlled, double-blinded, randomized, clinical trial

Casper Grønlund Larsen, Mikael Karlberg, Frank Guldfred, Louise Devantier, Mathias Maagaard, Preben Homøe, Bjarki Ditlev Djurhuus, Casper Grønlund Larsen, Mikael Karlberg, Frank Guldfred, Louise Devantier, Mathias Maagaard, Preben Homøe, Bjarki Ditlev Djurhuus

Abstract

Background: Menière's disease is an idiopathic disorder characterized by recurrent episodes of vertigo lasting more than 20 min, unilateral sensorineural hearing loss, and tinnitus. If vertigo attacks occur frequently, the patient is usually severely incapacitated. Currently, there is no consensus on the treatment of Menière's disease. The evidence regarding most treatment options is sparse due to a lack of randomized trials together with an often-spontaneous relief over time and a considerable placebo effect. Insertion of a transmyringeal tube is a simple and relatively safe, minimally invasive procedure and previous open-label trials have shown promising results.

Study design: This is a prospective, sham-controlled, double-blinded, randomized, clinical trial.

Aim: This trial aims to assess the effects of inserting a ventilation tube into the tympanic membrane compared with sham treatment for definite or probable unilateral Menière's disease according to the criteria formulated by the Classification Committee of the Bàràny Society.

Outcomes: The primary outcome will be the number of spontaneous vertigo attacks lasting more than 20 min and time to treatment failure. In addition to the primary outcome, we will assess various secondary outcomes related to hearing, ear fullness, dizziness, and serious adverse events.

Sample size: An estimated 104 participants in total or 52 participants in each group will be necessary. The primary analysis will be according to the intention-to-treat principle. The trial will be initiated in 2021 and is expected to end in 2025.

Trial status: ClinicalTrials.gov : NCT04835688 . Registered on April 8, 2021.

Protocol version: 1.8, 26-09-2022. Date of first enrollment: October 1st, 2021. End of study: anticipated January 2025.

Keywords: Menière; Menière’s disease; Randomized controlled trial; Ventilation tube insertion.

Conflict of interest statement

The authors declare that they have no competing interests.

© 2022. The Author(s).

References

    1. Espinosa-Sanchez JM, Lopez-Escamez JA. Meniere's disease. Handb Clin Neurol. 2016;137:257–277. doi: 10.1016/B978-0-444-63437-5.00019-4.
    1. Havia M, Kentala E, Pyykko I. Prevalence of Meniere's disease in general population of southern Finland. Otolaryngol Head Neck Surg. 2005;133(5):762–768. doi: 10.1016/j.otohns.2005.06.015.
    1. Radtke A, von Brevern M, Feldmann M, Lezius F, Ziese T, Lempert T, et al. Screening for Meniere's disease in the general population - the needle in the haystack. Acta Otolaryngol. 2008;128(3):272–276. doi: 10.1080/00016480701509933.
    1. Menière's disease The medical handbook 2018 [Available from: .
    1. Stahle J, Friberg U, Svedberg A. Long-term progression of Meniere's disease. Acta Otolaryngol Suppl. 1991;485:78–83. doi: 10.3109/00016489109128047.
    1. Coelho DH, Lalwani AK. Medical management of Meniere's disease. Laryngoscope. 2008;118(6):1099–1108. doi: 10.1097/MLG.0b013e31816927f0.
    1. Stokroos R, Kingma H. Selective vestibular ablation by intratympanic gentamicin in patients with unilateral active Meniere's disease: a prospective, double-blind, placebo-controlled, randomized clinical trial. Acta Otolaryngol. 2004;124(2):172–175. doi: 10.1080/00016480410016621.
    1. Postema RJ, Kingma CM, Wit HP, Albers FW, Van Der Laan BF. Intratympanic gentamicin therapy for control of vertigo in unilateral Menire's disease: a prospective, double-blind, randomized, placebo-controlled trial. Acta Otolaryngol. 2008;128(8):876–880. doi: 10.1080/00016480701762458.
    1. Tumarkin A. Thoughts on the treatment of labyrinthopathy. J Laryngol Otol. 1966;80(10):1041–1053. doi: 10.1017/S0022215100066366.
    1. Hall MC, Brackmann DE. Eustachian tube blockage and Meniere's disease. Arch Otolaryngol. 1977;103(6):355–357. doi: 10.1001/archotol.1977.00780230077012.
    1. Brattmo M, Tideholm B, Carlborg B. Inadequate opening capacity of the eustachian tube in Meniere's disease. Acta Otolaryngol. 2012;132(3):255–260. doi: 10.3109/00016489.2011.637175.
    1. Thomsen J, Bonding P, Becker B, Stage J, Tos M. The non-specific effect of endolymphatic sac surgery in treatment of Meniere's disease: a prospective, randomized controlled study comparing "classic" endolymphatic sac surgery with the insertion of a ventilating tube in the tympanic membrane. Acta Otolaryngol. 1998;118(6):769–773. doi: 10.1080/00016489850182413.
    1. Kimura RS, Hutta J. Inhibition of experimentally induced endolymphatic hydrops by middle ear ventilation. Eur Arch Otorhinolaryngol. 1997;254(5):213–218. doi: 10.1007/BF00874091.
    1. Committee on hearing and equilibrium guidelines for the diagnosis and evaluation of therapy in Meniere's disease. Otolaryngol Head Neck Surg. 1995;113(3):181–5. 10.1016/S0194-5998(95)70102-8.
    1. Chan AW, Tetzlaff JM, Gøtzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:e7586. doi: 10.1136/bmj.e7586.
    1. Lopez-Escamez JA, Carey J, Chung WH, Goebel JA, Magnusson M, Mandala M, et al. Diagnostic criteria for Meniere's disease. J Vestib Res. 2015;25(1):1–7. doi: 10.3233/VES-150549.
    1. Lopez-Escamez JA, Carey J, Chung WH, Goebel JA, Magnusson M, Mandala M, et al. Diagnostic criteria for Meniere's disease according to the classification Committee of the Barany Society. Hno. 2017;65(11):887–893. doi: 10.1007/s00106-017-0387-z.
    1. The local branch of the data agency in Region Zealand Region Zealand University Hospitals webpage.: Region Zealand University Hospital; 2021 [A description of the local branch of the data agency in Region Zealand University Hospital.]. Available from: .
    1. The danish national ethics committee The danish national ethics committee [Information on the danish compensation association]. Available from: .
    1. Defining the Role of Authors and Contributors: ICMJE; [Recommendations]. Available from: .

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다